{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:ct-nct07923526",
  "owner": "cardio",
  "kind": "study",
  "slug": "nct07923526",
  "name": "An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)",
  "aliases": [
    "NCT07923526"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 400 participants.",
  "summary_technical": "Registry record NCT07923526. Allocation not applicable; no masking; primary purpose treatment. Start 2027-03 (anticipated); primary completion 2034-09 (anticipated). Results not posted.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-18",
  "last_evidence_check": null,
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "nct",
      "value": "NCT07923526",
      "normalized_value": "NCT07923526",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "condition-area": [
        "coronary-and-vascular-disease"
      ],
      "system": [
        "blood-vessels",
        "heart"
      ]
    }
  },
  "payload": {
    "design": "Interventional study; allocation not applicable; no masking; primary purpose treatment",
    "drug_phase": "2/3",
    "registry_statuses": [
      {
        "status": "NOT_YET_RECRUITING",
        "snapshot": "cardio:ctgov-nct07923526-2026-11-06"
      }
    ],
    "start_date": {
      "date": "2027-03",
      "type": "anticipated",
      "snapshot": "cardio:ctgov-nct07923526-2026-11-06"
    },
    "primary_completion_date": {
      "date": "2034-09",
      "type": "anticipated",
      "snapshot": "cardio:ctgov-nct07923526-2026-11-06"
    },
    "completion_date": {
      "date": "2034-09",
      "type": "anticipated",
      "snapshot": "cardio:ctgov-nct07923526-2026-11-06"
    },
    "results_first_posted": null,
    "countries": [
      {
        "code": "US",
        "snapshot": "cardio:ctgov-nct07923526-2026-11-06"
      }
    ],
    "care_setting": null,
    "stopped_early": null,
    "enrollment": [
      {
        "count": 400,
        "basis": "planned",
        "unit": "participants",
        "snapshot": "cardio:ctgov-nct07923526-2026-11-06"
      }
    ],
    "arms": [],
    "findings": [],
    "registry": [
      {
        "label": "Brief title",
        "value": "An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)",
        "locator": "protocolSection.identificationModule.briefTitle"
      },
      {
        "label": "Acronym",
        "value": "SUMMIT OLE",
        "locator": "protocolSection.identificationModule.acronym"
      },
      {
        "label": "Condition",
        "value": "Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease",
        "locator": "protocolSection.conditionsModule.conditions[0]"
      },
      {
        "label": "Intervention (Combination product)",
        "value": "treprostinil SMI (treprostinil inhalation spray)",
        "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
      },
      {
        "label": "Lead sponsor",
        "value": "United Therapeutics",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
      },
      {
        "label": "Lead sponsor class",
        "value": "INDUSTRY",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.class"
      }
    ]
  },
  "content_digest": "bcbec09bd9271e50a30d1449f347b330fca385c582e2958dfd6bf3ec3efa7755",
  "review": {
    "content_digest": "bcbec09bd9271e50a30d1449f347b330fca385c582e2958dfd6bf3ec3efa7755",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "investigates",
        "label": "Registry condition terms include this condition",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:pulmonary-hypertension",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct07923526-2026-11-06",
          "locator": "derivedSection.conditionBrowseModule.meshes[0].id"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "sponsored_by",
        "label": "Registry lists this organization as the lead sponsor",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:org-united-therapeutics",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct07923526-2026-11-06",
          "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
        },
        "primary": false,
        "role": "lead",
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "studies/nct07923526/",
  "context_path": "api/v1/context/cardio--ct-nct07923526.md"
}
